Axonics Past Earnings Performance
Past criteria checks 0/6
Axonics has been growing earnings at an average annual rate of 28.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 41.3% per year.
Key information
28.1%
Earnings growth rate
38.0%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | 41.3% |
| Return on equity | -0.9% |
| Net Margin | -1.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Axonics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 432 | -6 | 282 | 47 |
| 30 Jun 24 | 409 | -2 | 265 | 42 |
| 31 Mar 24 | 387 | -16 | 252 | 38 |
| 31 Dec 23 | 366 | -6 | 235 | 35 |
| 30 Sep 23 | 343 | -12 | 223 | 33 |
| 30 Jun 23 | 320 | -32 | 213 | 33 |
| 31 Mar 23 | 296 | -46 | 208 | 31 |
| 31 Dec 22 | 274 | -60 | 196 | 34 |
| 30 Sep 22 | 241 | -76 | 181 | 36 |
| 30 Jun 22 | 217 | -77 | 168 | 37 |
| 31 Mar 22 | 194 | -80 | 151 | 39 |
| 31 Dec 21 | 180 | -80 | 136 | 37 |
| 30 Sep 21 | 162 | -76 | 121 | 35 |
| 30 Jun 21 | 150 | -68 | 109 | 34 |
| 31 Mar 21 | 120 | -63 | 95 | 32 |
| 31 Dec 20 | 112 | -55 | 92 | 29 |
| 30 Sep 20 | 87 | -66 | 89 | 27 |
| 30 Jun 20 | 53 | -82 | 87 | 24 |
| 31 Mar 20 | 39 | -81 | 82 | 23 |
| 31 Dec 19 | 14 | -80 | 68 | 20 |
| 30 Sep 19 | 4 | -67 | 51 | 19 |
| 30 Jun 19 | 3 | -49 | 34 | 18 |
| 31 Mar 19 | 2 | -39 | 21 | 19 |
| 31 Dec 18 | 1 | -32 | 13 | 19 |
| 30 Sep 18 | 0 | -28 | 10 | 18 |
| 30 Jun 18 | 0 | -25 | 7 | 17 |
| 31 Mar 18 | 0 | -20 | 6 | 14 |
| 31 Dec 17 | 0 | -18 | 6 | 12 |
Quality Earnings: 0I3 is currently unprofitable.
Growing Profit Margin: 0I3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0I3 is unprofitable, but has reduced losses over the past 5 years at a rate of 28.1% per year.
Accelerating Growth: Unable to compare 0I3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0I3 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21%).
Return on Equity
High ROE: 0I3 has a negative Return on Equity (-0.85%), as it is currently unprofitable.